| Range: | 3.0E-4-0.055 | Vol Avg: | 16510 | Last Div: | 0 | Changes: | 0 |
| Beta: | 0 | Cap: | 0.05B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Financial Services | IPO: | Mon Nov 22 2021 | Empoloyees: | |||
| CUSIP: | 61240F116 | CIK: | 0001860663 | ISIN: | Country: | US | |
| CEO: | Dr. Sanjeev Satyal Ph.D. | Website: | https://www.montereybio.com | ||||
MTRYW 0.00 Stock Price Monterey Bio Acquisition Corporation
Monterey Bio Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to acquire businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow